Cite

HARVARD Citation

    Chen, H. et al. (2021). MiR‐218 contributes to drug resistance in multiple myeloma via targeting LRRC28. Journal of cellular biochemistry. 122 (3), pp. 305-314. [Online]. 
  
Back to record